Manufacturer
AbbVie
Pharmaceutical manufacturer based in United States
United States
- Products listed
- 75
- Molecules
- 23
- Therapy areas
- 8
AbbVie is a pharmaceutical manufacturer based in United States. MedsAcross lists 75 of its products across 23 molecules, each with registers, packs and availability for export supply to licensed buyers.
- Country
- United States
- Indian manufacturer
- No
- Also listed as
- AbbVie Inc., AbbVie Limited
- EU marketing authorisation holder
- YesSource: European Medicines Agency
- US FDA labeler
- YesSource: openFDA NDC directory
Source from this manufacturer
We supply AbbVie products through licensed channels, with the documents your regulator needs.
Endocrinology
17 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Synthroid 100 mcg tabletOral | Levothyroxine | US FDA | Available on request |
| Synthroid 112 mcg tabletOral | Levothyroxine | US FDA | Available on request |
| Synthroid 125 mcg tabletOral | Levothyroxine | US FDA | Available on request |
| Synthroid 137 mcg tabletOral | Levothyroxine | US FDA | Available on request |
| Synthroid 150 mcg tabletOral | Levothyroxine | US FDA | Available on request |
| Synthroid 175 mcg tabletOral | Levothyroxine | US FDA | Available on request |
| Synthroid 200 mcg tabletOral | Levothyroxine | US FDA | Available on request |
| Synthroid 25 mcg tabletOral | Levothyroxine | US FDA | Available on request |
| Synthroid 300 mcg tabletOral | Levothyroxine | US FDA | Available on request |
| Synthroid 50 mcg tabletOral | Levothyroxine | US FDA | Available on request |
| Synthroid 75 mcg tabletOral | Levothyroxine | US FDA | Available on request |
| Synthroid 88 mcg tabletOral | Levothyroxine | US FDA | Available on request |
| Zemplar 1 mcg capsuleOral | Paricalcitol | US FDA | Available on request |
| Zemplar 10 mcg/2 mL injectionIntravenous | Paricalcitol | US FDA | Available on request |
| Zemplar 2 mcg capsuleOral | Paricalcitol | US FDA | Available on request |
| Zemplar 2 mcg/1 mL injectionIntravenous | Paricalcitol | US FDA | Available on request |
| Zemplar 5 mcg/1 mL injectionIntravenous | Paricalcitol | US FDA | Available on request |
Immunology and transplant
13 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Gengraf 100 mg capsuleOral | Cyclosporine | US FDA | Available on request |
| Gengraf 25 mg capsuleOral | Cyclosporine | US FDA | Available on request |
| Humira kit Cold chain | Adalimumab | US FDA | Available on request |
| Rinvoq 1 mg/mL oral solutionOral | Upadacitinib | US FDA | Available on request |
| Rinvoq 15 mg extended-release tabletOral | Upadacitinib | US FDA | Available on request |
| Rinvoq 30 mg extended-release tabletOral | Upadacitinib | US FDA | Available on request |
| Rinvoq 45 mg extended-release tabletOral | Upadacitinib | US FDA | Available on request |
| Skyrizi kit Cold chain | Risankizumab | US FDA | Available on request |
| Skyrizi kitIntravenous Cold chain | Risankizumab | US FDA | Available on request |
| Skyrizi 150 mg/1 mL injectionSubcutaneous Cold chain | Risankizumab | US FDA | Available on request |
| Skyrizi 180 mg/1.2 mL injectionSubcutaneous Cold chain | Risankizumab | US FDA | Available on request |
| Skyrizi 55 mg/0.37 mL injectionSubcutaneous Cold chain | Risankizumab | US FDA | Available on request |
| Skyrizi 600 mg/10 mL injectionIntravenous Cold chain | Risankizumab | US FDA | Available on request |
Oncology
9 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Lupron Depot kit | Leuprolide | US FDA | Available on request |
| Lupron Depot kit | Leuprolide | US FDA | Available on request |
| Lupron Depot kit | Leuprolide | US FDA | Available on request |
| Lupron Depot kit | Leuprolide | US FDA | Available on request |
| Lupron Depot-PED kit | Leuprolide | US FDA | Available on request |
| Venclexta kit | Venetoclax | US FDA | Available on request |
| Venclexta 10 mg tabletOral | Venetoclax | US FDA | Available on request |
| Venclexta 100 mg tabletOral | Venetoclax | US FDA | Available on request |
| Venclexta 50 mg tabletOral | Venetoclax | US FDA | Available on request |
Neurology
7 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Depakote 125 mg delayed-release tabletOral | Divalproex | US FDA | Available on request |
| Depakote 250 mg delayed-release tabletOral | Divalproex | US FDA | Available on request |
| Depakote 500 mg delayed-release tabletOral | Divalproex | US FDA | Available on request |
| Depakote ER 250 mg extended-release tabletOral | Divalproex | US FDA | Available on request |
| Depakote ER 500 mg extended-release tabletOral | Divalproex | US FDA | Available on request |
| Depakote Sprinkles 125 mg capsuleOral | Divalproex | US FDA | Available on request |
| Duopa 4.63 mg/20 mg per mL oral suspensionEnteral Cold chain | Carbidopa and Levodopa | US FDA | Available on request |
HIV
5 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Kaletra 100 mg/25 mg tabletOral Cold chain | Lopinavir and Ritonavir | US FDA | Available on request |
| Kaletra 200 mg/50 mg tabletOral Cold chain | Lopinavir and Ritonavir | US FDA | Available on request |
| Kaletra 80 mg/20 mg per mL oral solutionOral Cold chain | Lopinavir and Ritonavir | US FDA | Available on request |
| Norvir 100 mg tabletOral | Ritonavir | US FDA | Available on request |
| Norvir 100 mg oral powderOral | Ritonavir | US FDA | Available on request |
Pain and anaesthesia
4 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Qulipta 10 mg tabletOral | Atogepant | US FDA | Available on request |
| Qulipta 30 mg tabletOral | Atogepant | US FDA | Available on request |
| Qulipta 60 mg tabletOral | Atogepant | US FDA | Available on request |
| Ultane 250 mL/250 mL inhalation solutionInhalation | Sevoflurane | US FDA | Available on request |
Hepatitis B and C
2 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Mavyret 100 mg/40 mg tabletOral | Glecaprevir and Pibrentasvir | US FDA | Available on request |
| Mavyret 50 mg/20 mg oral pelletsOral | Glecaprevir and Pibrentasvir | US FDA | Available on request |
Antibiotics
1 presentation
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Emblaveo 42.3 mg/127 mg per mL powder for injectionIntravenous | Avibactam and Aztreonam | US FDA | Available on request |
Other products
17 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Creon 120000 units/24000 units/76000 units delayed-release capsuleOral | Pancrelipase amylase, Pancrelipase lipase and Pancrelipase protease | US FDA | Available on request |
| Creon 15000 units/3000 units/9500 units delayed-release capsuleOral | Pancrelipase amylase, Pancrelipase lipase and Pancrelipase protease | US FDA | Available on request |
| Creon 180000 units/36000 units/114000 units delayed-release capsuleOral | Pancrelipase amylase, Pancrelipase lipase and Pancrelipase protease | US FDA | Available on request |
| Creon 30000 units/6000 units/19000 units delayed-release capsuleOral | Pancrelipase amylase, Pancrelipase lipase and Pancrelipase protease | US FDA | Available on request |
| Creon 60000 units/12000 units/38000 units delayed-release capsuleOral | Pancrelipase amylase, Pancrelipase lipase and Pancrelipase protease | US FDA | Available on request |
| Decnupaz 2 mg/mL powder for injectionIntravenous Cold chain | Pivekimab sunirine | US FDA | Available on request |
| Emrelis 100 mg/mL powder for injectionIntravenous Cold chain | Telisotuzumab vedotin | US FDA | Available on request |
| Emrelis 20 mg/mL powder for injectionIntravenous Cold chain | Telisotuzumab vedotin | US FDA | Available on request |
| Juvmo kit | Tavapadon | US FDA | Available on request |
| Juvmo 0.25 mg tabletOral | Tavapadon | US FDA | Available on request |
| Juvmo 10 mg tabletOral | Tavapadon | US FDA | Available on request |
| Juvmo 15 mg tabletOral | Tavapadon | US FDA | Available on request |
| Juvmo 5 mg tabletOral | Tavapadon | US FDA | Available on request |
| Orilissa 150 mg tabletOral | Elagolix | US FDA | Available on request |
| Orilissa 200 mg tabletOral | Elagolix | US FDA | Available on request |
| Survanta 25 mg/mL inhalation suspensionEndotracheal Cold chain | Beractant | US FDA | Available on request |
| Vyalev 120 mg/2400 mg per 10 mL injectionSubcutaneous Cold chain | Foscarbidopa and Foslevodopa | US FDA | Available on request |
Molecules made
Pancrelipase amylase, Pancrelipase lipase and Pancrelipase proteasePivekimab sunirineDivalproexCarbidopa and LevodopaAvibactam and AztreonamTelisotuzumab vedotinCyclosporineAdalimumabTavapadonLopinavir and RitonavirLeuprolideGlecaprevir and PibrentasvirRitonavirElagolixAtogepantUpadacitinibRisankizumabBeractantLevothyroxineSevofluraneVenetoclaxFoscarbidopa and FoslevodopaParicalcitol
Manufacturer facts come from public registers and are shown with their source. Listing does not mean the manufacturer endorses MedsAcross.
Source from AbbVie
Send a request for any of these products. We confirm the licensed source, documents and lead time.